Skip to main content
. 2021 Apr 19;4(4):e216433. doi: 10.1001/jamanetworkopen.2021.6433

Table 2. Bivariate Analysis of Index Emergency Department Variables Associated With Hospitalization.

Variable Admission to hospital, No./total No. (%) Model results
No (n = 1775) Yes (n = 67) Unadjusted OR (95% CI)a P valueb
Sex
Boys 971/1005 (96.6) 34/1005 (3.4) 1 [Reference] .52
Girls 804/837 (96.1) 33/837 (3.9) 1.17 (0.72-1.92)
Age group, mo
3.0 to <12.0 583/611 (95.4) 28/611 (4.6) 1 [Reference] .48
12.0 to <24.0 655/678 (96.6) 23/678 (3.4) 0.79 (0.45-1.39)
24.0 to <36.0 326/337 (96.7) 11/337 (3.3) 0.70 (0.34-1.44)
36.0 to <48.0 211/216 (97.7) 5/216 (2.3) 0.50 (0.19-1.32)
ED location
Canada 854/876 (97.5) 22/876 (2.5) 1 [Reference] .15
US 921/966 (95.3) 45/966 (4.7) 1.81 (0.80-4.12)
Distance from home to ED, median (IQR), kmb 8.8 (4.5-15.2) 11.7 (5.1-31.0) 1.23 (1.12-1.36) <.001
Infectious agentc
Negative 646/661 (97.7) 15/661 (2.3) 1 [Reference] .004
Isolated organism
Bacteria 97/99 (98.0) 2/99 (2.0) 0.88 (0.19-3.93)
Virus 765/810 (94.4) 45/810 (5.6) 2.89 (1.58-5.31)
Virus/bacteria codetection 29/30 (96.7) 1/30 (3.3) 1.89 (0.23-15.30)
Parasitesd 19/19 (100.0) 0/19 NA
Clinical Dehydration Scale score
None (0) 1105/1114 (99.2) 9/1114 (0.8) 1 [Reference] <.001
Mild to moderate (1-4) 633/681 (93.0) 48/681 (7.0) 11.84 (5.67-24.71)
Severe (5-8) 30/40 (75.0) 10/40 (25.0) 53.45 (19.10-149.57)
Oral ondansetron administered in the EDe
No 1253/1308 (95.8) 55/1308 (4.2) 1 [Reference] .02
Yes 522/534 (97.8) 12/534 (2.2) 0.47 (0.25-0.89)
No. of diarrhea episodes in 24 h preceding index ED visit, median (IQR)b 5.0 (4.0-8.0) 8.0 (4.0-15.0) 1.67 (1.39-2.01) <.001
Duration of diarrhea, h
1 to <96 1593/1648 (96.7) 55/1648 (3.3) 1 [Reference] .15
96 to <120 88/96 (91.7) 8/96 (8.3) 2.21 (0.99-4.94)
≥120 79/83 (95.2) 4/83 (4.8) 1.28 (0.44-3.70)
No. of vomiting episodes in 24 h preceding index ED visit, median (IQR)b 2.0 (0.0-5.0) 4.0 (1.0-8.0) 1.50 (1.25-1.81) <.001
Duration of vomiting, h
No vomiting 430/437 (98.4) 7/437 (1.6) 1 [Reference] .06
1 to <24 388/405 (95.8) 17/405 (4.2) 2.62 (1.07-6.43)
24 to <48 354/367 (96.5) 13/367 (3.5) 2.33 (0.91-5.99)
≥48 478/504 (94.8) 26/504 (5.2) 3.21 (1.37-7.56)
Preceding health care practitioner visit
No 1511/1556 (97.1) 45/1556 (2.9) 1 [Reference] <.001
Yes, but no IV rehydration 243/261 (93.1) 18/261 (6.9) 2.21 (1.24-3.94)
Yes, with IV rehydration 12/16 (75.0) 4/16 (25.0) 10.26 (3.11-33.86)
Feverf
No 840/861 (97.6) 21/861 (2.4) 1 [Reference] .02
Yes 935/981 (95.3) 46/981 (4.7) 1.93 (1.14-3.28)

Abbreviations: ED, emergency department; IV, intravenous; NA, not available; OR, odds ratio; PECARN, Pediatric Emergency Care Applied Research Network; PERC, Pediatric Emergency Research Canada.

a

ORs and CIs compare the odds of being admitted for each group vs the reference category or for an increase of 5 vomit or diarrhea episodes or for a 10-km increase in geodetic distance between a patient’s residence and the hospital zip code. A random effect of enrolling clinical site is included in all models. Models are otherwise unadjusted.

b

Five participants did not report a zip code; 2 did not report a number of vomiting or diarrhea episodes in 24 hours preceding the index ED visit.

c

Includes participants in whom stool testing was performed and results were available; patients with isolated parasites excluded from estimation of ORs due to low numbers.

d

Parasites alone were detected in 12 participants; parasite and virus or parasite and bacteria were codetected in 7 participants.

e

Excluding oral ondansetron given within 30 minutes or after ordering IV fluid.

f

Fever was defined as rectal temperature ≥38.0 °C in the PERC cohort; tactile fever or temperature ≥38.0 °C adjusted to rectal temperature in the PECARN cohort during the current illness, either at home or in the ED.